Last update 08 May 2025

Pentavalent-specific T cells(George Papanicolaou Hospital)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms
penta-STs
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Infectious DiseasesOther Diseases
Active Indication
Adenoviridae InfectionsOpportunistic fungal infectionOpportunistic viral infection+ [1]
Inactive Indication-
Originator Organization
George Papanicolaou Hospital
Active Organization
George Papanicolaou Hospital
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Pentavalent-specific T cells(George Papanicolaou Hospital)
NCT05471661
/ CompletedPhase 1/2IIT
Administration of Rapidly Generated Multipathogen-specific T-Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections Post Allogeneic Stem Cell Transplant
100 Clinical Results associated with Pentavalent-specific T cells(George Papanicolaou Hospital)
Login to view more data
100 Translational Medicine associated with Pentavalent-specific T cells(George Papanicolaou Hospital)
Login to view more data
100 Patents (Medical) associated with Pentavalent-specific T cells(George Papanicolaou Hospital)
Login to view more data
100 Deals associated with Pentavalent-specific T cells(George Papanicolaou Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenoviridae InfectionsPhase 2
Greece
George Papanicolaou Hospital
22 May 2021
Opportunistic fungal infectionPhase 2
Greece
George Papanicolaou Hospital
22 May 2021
Opportunistic viral infectionPhase 2
Greece
George Papanicolaou Hospital
22 May 2021
Postoperative infectionPhase 2
Greece
George Papanicolaou Hospital
22 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free